Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
SGLT-2 inhibitors offer benefits beyond glucose control, potentially addressing the systemic inflammatory components of metabolic diseases like diabetes, heart failure, and gout.
Cardiology July 22nd 2024
Despite its theoretical benefits, IV albumin has not shown consistent superiority over crystalloid solutions in sepsis management, prompting a reevaluation of fluid resuscitation strategies in critical care settings.
Emergency Medicine July 16th 2024
The New England Journal of Medicine
AL amyloidosis presents a diagnostic challenge due to its varied symptoms, but advancements in therapeutic options, including CyBorD plus daratumumab and emerging antifibril monoclonal antibodies, offer hope for better patient management.
Cardiology July 9th 2024
This case study details the diagnostic process of a young male with hypokalemia and metabolic alkalosis, culminating in the identification of an ectopic ACTH-producing pulmonary carcinoid tumor.
Endocrinology, Diabetes, Metabolism July 3rd 2024
GoodRx Health
NSAIDs, diuretics, and ACE inhibitors are among the top medications linked to kidney damage. Understanding their risks and managing their use is crucial for protecting renal health in patients with varying medical histories.
Nephrology July 3rd 2024
A recent randomized trial demonstrated that intravenous amino acid infusions can significantly reduce the incidence of acute kidney injury in patients undergoing cardiac surgery, highlighting a potential new approach to mitigating this common complication.
Cardiology June 20th 2024